دورية أكاديمية
COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance.
| العنوان: | COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance. |
|---|---|
| المؤلفون: | Bermas BL; B.L. Bermas, MD, UTSouthwestern Medical Center, Dallas, Texas, USA., Gianfrancesco M; M. Gianfrancesco, MPH, PhD, A.M. Seet, MPH, J. Yazdany, MPH, MD, Division of Rheumatology, School of Medicine, University of California, San Francisco, California, USA., Tanner HL; H.L. Tanner, MBChB, FRACP, University of Queensland School of Clinical Medicine, Faculty of Medicine, Queensland, Australia., Seet AM; M. Gianfrancesco, MPH, PhD, A.M. Seet, MPH, J. Yazdany, MPH, MD, Division of Rheumatology, School of Medicine, University of California, San Francisco, California, USA., Aguiar MC; M.C. Aguiar, MD, Hospital General Agustin O'Horan, Merida, Mexico., Al Adhoubi NK; N.K. Al Adhoubi, MD, FRCP, Rheumatology Unit, Royal Hospital, Muscat, Oman., Al Emadi S; S. Al Emadi, MBBS, FRCPC, Hamad Medical Corporation, Doha, Qatar., Cunha BM; B.M. Cunha, MD, PhD, Sarah Network of Rehabilitation Hospitals, Brasília, Brazil., Flood R; R. Flood, MB, BCh, BAO, Tallaght University Hospital, Tallaght, Dublin, Ireland., Kusevich DA; D.A. Kusevich, MD,PhD, V.A. Nasonova Research Institute of Rheumatology, Moscow, and Anikina Clinic, Vidnoe, Russia., McCarthy EM; E.M. McCarthy, MB, MRCPI, Manchester University Foundation Trust, Manchester, UK., Patel NJ; N.J. Patel, MD, Massachusetts General Hospital, Boston, Massachusetts, USA., Ruderman EM; E.M. Ruderman, MD, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Sattui SE; S.E. Sattui, MD, MS, Hospital for Special Surgery, New York, New York, USA., Sciascia S; S. Sciascia, MD, PhD, Center of Research of Immunopathology and Rare Diseases/Nephrology and Dialysis Unit, Department of Clinical and Biological Sciences, S. Giovanni Bosco Hospital, Turin, Italy., Siddique F; F. Siddique, MD, Loyola University Medical Center, Maywood, Illinois, USA., Valenzuela-Almada MO; M.O. Valenzuela-Almada, MBBS, A. Duarte-Garcia, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA., Wise LM; L.M. Wise, MD, University of Southern California, Los Angeles, California, USA., Worthing AB; A.B. Worthing, MD, Arthritis & Rheumatism Associates, PC, and Georgetown University Medical Center, Washington, DC, USA., Zell J; J. Zell, MD, University of Colorado, Aurora, Colorado, USA., Bhana S; S. Bhana, MD, Crystal Run Healthcare, Middletown, New York, USA., Costello W; W. Costello, Irish Children's arthritis network (iCan), Tipperary, Ireland., Duarte-Garcia A; M.O. Valenzuela-Almada, MBBS, A. Duarte-Garcia, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA., Grainger R; R. Grainger, MBChB, PhD, FRACP, Department of Medicine, University of Otago, Wellington, New Zealand., Gossec L; L. Gossec, MD, PhD, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, and Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Rheumatology Department, Paris, France., Hausmann JS; J.S. Hausmann, MD, Program in Rheumatology, Division of Immunology, Boston Children's Hospital, and Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Hyrich K; K. Hyrich, MD, PhD, FRCPC, Centre for Epidemiology Versus Arthritis, The University of Manchester, and National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK., Lawson-Tovey S; S. Lawson-Tovey, BA, National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, and Centre for Genetics and Genomics Versus Arthritis, The University of Manchester, Manchester, UK., Liew JW; J.W. Liew, MS, MD, Boston University School of Medicine, Boston, Massachusetts, USA., Sirotich E; E. Sirotich, BSc, Department of Health Research, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., Sparks JA; J.A. Sparks, MD, MMSc, Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Sufka P; P. Sufka, MD, Healthpartners, St. Paul, Minnesota, USA., Wallace ZS; Z.S. Wallace, MD, MSc, Rheumatology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Machado PM; P.M. Machado, MD, PhD, Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, and National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, and Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK., Strangfeld A; A. Strangfeld, MD, Epidemiology Unit, German Rheumatism Research Centre (DRFZ) Berlin, Berlin, Germany., Clowse MEB; M.E.B. Clowse, MD, MPH, Duke University School of Medicine, Durham, North Carolina, USA., Yazdany J; M. Gianfrancesco, MPH, PhD, A.M. Seet, MPH, J. Yazdany, MPH, MD, Division of Rheumatology, School of Medicine, University of California, San Francisco, California, USA., Robinson PC; P.C. Robinson, MBChB, PhD, FRACP, Associate Professor, University of Queensland School of Clinical Medicine, Faculty of Medicine, Queensland, Australia, and Royal Brisbane & Women's Hospital, Metro North Hospital & Health Service, Herston, Queensland, Australia. philip.robinson@uq.edu.au. |
| المصدر: | The Journal of rheumatology [J Rheumatol] 2022 Jan; Vol. 49 (1), pp. 110-114. Date of Electronic Publication: 2021 Sep 01. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0315-162X (Print) Linking ISSN: 0315162X NLM ISO Abbreviation: J Rheumatol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Toronto : Journal Of Rheumatology Publishing Co Original Publication: Toronto. |
| مواضيع طبية MeSH: | COVID-19* , Rheumatic Diseases*/therapy , Rheumatology*, Adult ; COVID-19 Testing ; Female ; Humans ; Infant, Newborn ; Middle Aged ; Pregnancy ; Pregnant Women ; SARS-CoV-2 ; Young Adult |
| مستخلص: | Objective: To describe coronavirus disease 2019 (COVID-19) and pregnancy outcomes in patients with rheumatic disease who were pregnant at the time of infection. Methods: Since March 2020, the COVID-19 Global Rheumatology Alliance has collected cases of patients with rheumatic disease with COVID-19. We report details of pregnant women at the time of COVID-19 infection, including obstetric details separately ascertained from providers. Results: We report on 39 patients, including 22 with obstetric detail available. The mean and median age was 33 years, range 24-45 years. Rheumatic disease diagnoses included rheumatoid arthritis (n = 9), systemic lupus erythematosus (n = 9), psoriatic arthritis/other inflammatory arthritides (n = 8), and antiphospholipid syndrome (n = 6). Most had a term birth (16/22), with 3 preterm births, 1 termination, and 1 miscarriage; 1 woman had yet to deliver at the time of report. One-quarter (n = 10/39) of pregnant women were hospitalized following COVID-19 diagnosis. Two of 39 (5%) required supplemental oxygen (both hospitalized); no patients died. The majority did not receive specific medication treatment for their COVID-19 (n = 32/39, 82%), and 7 patients received some combination of antimalarials, colchicine, anti-interleukin 1β, azithromycin, glucocorticoids, and lopinavir/ritonavir. Conclusion: Women with rheumatic diseases who were pregnant at the time of COVID-19 had favorable outcomes. These data have limitations due to the small size and methodology; however, they provide cautious optimism for pregnancy outcomes for women with rheumatic disease particularly in comparison to the increased risk of poor outcomes that have been reported in other series of pregnant women with COVID-19. (© 2022 The Journal of Rheumatology.) |
| التعليقات: | Comment in: J Rheumatol. 2022 Jan;49(1):5-7. (PMID: 34654736) |
| فهرسة مساهمة: | Keywords: COVID-19; anti-TNF; disease-modifying antirheumatic drug; rheumatoid arthritis; rheumatology |
| تواريخ الأحداث: | Date Created: 20210902 Date Completed: 20220107 Latest Revision: 20230701 |
| رمز التحديث: | 20240628 |
| DOI: | 10.3899/jrheum.210480 |
| PMID: | 34470798 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 0315-162X |
|---|---|
| DOI: | 10.3899/jrheum.210480 |